Status:
ENROLLING_BY_INVITATION
Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19
Lead Sponsor:
University of Manchester
Conditions:
SARS Virus
Eligibility:
All Genders
18+ years
Brief Summary
A team at the University of Manchester are developing a test that tcould be helpful in detecting immunity to the Coronavirus (which causes the COVID-19 disease) in participants with inflammatory arthr...
Eligibility Criteria
Inclusion
- Has previously taken part in either the BRAGGSS or National Repository Healthy Volunteer Study
- Has agreed to be contacted abut future research projects
- Has previously provided a blood sample for either the BRAGGSS or National Repository Healthy Volunteer Study
- Is willing to complete the informed consent form, registration slip, questionnaire and provide a 40ml blood sample
- Has a good written understanding of English
Exclusion
- Has not previously taken part in either the BRAGGSS or National Repository Healthy Volunteer Study
- Has not agreed to be contacted abut future research projects
- Has not previously provided a blood sample for either the BRAGGSS or National Repository Healthy Volunteer Study
- Is not willing to complete the informed consent form, registration slip, questionnaire and provide a 40ml blood sample
- Has not got a good written understanding of English
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT04363047
Start Date
October 1 2020
End Date
July 31 2026
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Manchester
Manchester, Greater Manchester, United Kingdom, M13 9WL